Current role
Biotechnology · Healthcare
Board Member
2023-06-01–present
Andrew Allen, MD, PhD
Board Member
Adaptimmune Therapeutics PLC (ADAPY)Equibles does not estimate personal net worth.
Get an email with a short summary when Adaptimmune Therapeutics PLC publishes a filing, an earnings call transcript or a press release.
Get ADAPY alertsAbout Andrew Allen, MD, PhD
Andrew Allen, MD, PhD is recorded as Board Member at Adaptimmune Therapeutics PLC (ADAPY) since June 1, 2023. Adaptimmune Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Adaptimmune Therapeutics PLC includes Adrian Rawcliffe (CEO and Board Member), David M. Mott (Chairman), Christopher Hill (CFO) and 7 others.
Affiliation history
-
Current
2023-06-01–present
Company network
Leadership on record at Adaptimmune Therapeutics PLC
- Adrian Rawcliffe CEO, Board Member
- David M. Mott Chairman
- Christopher Hill CFO
- William Bertrand COO
- Ali Behbahani Board Member
- Andrew Allen Board Member
- Andrew R. Allen Board Member
- Dr Priti Hegde Board Member
- Garry E. Menzel Board Member
- Garry Menzel Board Member
Recent activity
No call appearances or filed executive changes recorded yet.